Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health
Study. N Engl J Med.1989;321:129-135.
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy,
I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet
therapy in various categories of patients. BMJ.1994;308:81-106.
Second International Study of Infarct Survival (ISIS-2) Collaborative
Group. Randomised trial of intravenous streptokinase, oral aspirin, both,
or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet.1988;2:349-360.
Leor J, Reicher-Reiss H, Goldbourt U.
et al. Aspirin and mortality in patients treated with angiotensin-converting
enzyme inhibitors: a cohort study of 11,575 patients with coronary artery
disease. J Am Coll Cardiol.1999;33:1920-1925.
Harpaz D, Gottlieb S, Graff E, Boyko V, Kishon Y, Behar S.for the Israeli Bezafibrate Infarction Prevention Study Group. Effects of aspirin treatment on survival in non-insulin-dependent diabetic
patients with coronary artery disease. Am J Med.1998;105:494-499.
Krumholz HM, Chen YT, Radford MJ. Aspirin and the treatment of heart failure in the elderly. Arch Intern Med.2001;161:577-582.
Joffe MM, Rosenbaum PR. Invited commentary: propensity scores. Am J Epidemiol.1999;150:327-333.
Lauer MS, Mehta R, Pashkow FJ, Okin PM, Lee K, Marwick TH. Association of chronotropic incompetence with echocardiographic ischemia
and prognosis. J Am Coll Cardiol.1998;32:1280-1286.
Nishime EO, Cole CR, Blackstone EH, Pashkow FJ, Lauer MS. Heart rate recovery and treadmill exercise score as predictors of mortality
in patients referred for exercise ECG. JAMA.2000;284:1392-1398.
Joint National Committee on Detection, Evaluation, and Treatment of
High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation,
and Treatment of High Blood Pressure (JNC V). Arch Intern Med.1993;153:154-183.
Hubbard BL, Gibbons RJ, Lapeyre III AC, Zinsmeister AR, Clements IP. Identification of severe coronary artery disease using simple clinical
parameters. Arch Intern Med.1992;152:309-312.
Gibbons RJ, Balady GJ, Beasley JW.
et al. ACC/AHA Guidelines for Exercise Testing: a report of the American College
of Cardiology/American Heart Association Task Force on Practice Guidelines
(Committee on Exercise Testing). J Am Coll Cardiol.1997;30:260-311.
Snader CE, Marwick TH, Pashkow FJ, Harvey SA, Thomas JD, Lauer MS. Importance of estimated functional capacity as a predictor of all-cause
mortality among patients referred for exercise thallium single-photon emission
computed tomography: report of 3,400 patients from a single center. J Am Coll Cardiol.1997;30:641-648.
Lauer MS, Francis GS, Okin PM, Pashkow FJ, Snader CE, Marwick TH. Impaired chronotropic response to exercise stress testing as a predictor
of mortality. JAMA.1999;281:524-529.
Cole CR, Blackstone EH, Pashkow FJ, Snader CE, Lauer MS. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med.1999;341:1351-1357.
Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol.1999;34:618-620.
Boyle CA, Decoufle P. National sources of vital status information: extent of coverage and
possible selectivity in reporting. Am J Epidemiol.1990;131:160-168.
Newman TB, Brown AN. Use of commercial record linkage software and vital statistics to identify
patient deaths. J Am Med Inform Assoc.1997;4:233-237.
Cox D. Regression models and life tables (with discussion). J R Stat Soc B.1972;34:187-220.
Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc.1958;53:457-481.
Hosmer D, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons; 1989.
Blackstone EH, Naftel DC, Turner MEJ. The decomposition of time-varying hazard into phases, each incorporating
a separate stream of concomitant information. J Am Stat Assoc.1986;81:615-624.
Lytle BW, Blackstone EH, Loop FD.
et al. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg.1999;117:855-872.
Kestin AS, Ellis PA, Barnard MR, Errichetti A, Rosner BA, Michelson AD. Effect of strenuous exercise on platelet activation state and reactivity. Circulation.1993;88(pt 1):1502-1511.
Medical Research Council's General Practice Research Framework. Thrombosis prevention trial: randomised trial of low-intensity oral
anticoagulation with warfarin and low-dose aspirin in the primary prevention
of ischaemic heart disease in men at increased risk. Lancet.1998;351:233-241.
Manson JE, Stampfer MJ, Colditz GA.
et al. A prospective study of aspirin use and primary prevention of cardiovascular
disease in women. JAMA.1991;266:521-527.
Peto R, Gray R, Collins R.
et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed).1988;296:313-316.
Ridker PM, Manson JE, Gaziano JM, Buring JE, Hennekens CH. Low-dose aspirin therapy for chronic stable angina: a randomized, placebo-controlled
clinical trial. Ann Intern Med.1991;114:835-839.
Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R.for the Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Double-blind trial of aspirin in primary prevention of myocardial infarction
in patients with stable chronic angina pectoris. Lancet.1992;340:1421-1425.
RISC Group. Risk of myocardial infarction and death during treatment with low dose
aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet.1990;336:827-830.
Lewis Jr HD, Davis JW, Archibald DG.
et al. Protective effects of aspirin against acute myocardial infarction and
death in men with unstable angina: results of a Veterans Administration Cooperative
Study. N Engl J Med.1983;309:396-403.
Cairns JA, Gent M, Singer J.
et al. Aspirin, sulfinpyrazone, or both in unstable angina: results of a Canadian
multicenter trial. N Engl J Med.1985;313:1369-1375.
Theroux P, Ouimet H, McCans J.
et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med.1988;319:1105-1111.
Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a
randomised trial in general practice. Lancet.2001;357:89-95.
Moses LE. Measuring effects without randomized trials? options, problems, challenges. Med Care.1995;33(suppl 4):AS8-AS14.
Cairns P, Butany J, Fulop J, Rakowski H, Hassaram S. Cardiac presentation of non-Hodgkin's lymphoma. Arch Pathol Lab Med.1987;111:80-83.
Cook NR, Hebert PR, Manson JE, Buring JE, Hennekens CH. Self-selected posttrial aspirin use and subsequent cardiovascular disease
and mortality in the Physicians' Health Study. Arch Intern Med.2000;160:921-928.
Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet aggregability and
metabolites of thromboxane A2 and prostacyclin. Stroke.1992;23:1400-1403.
Tschoepe D, Schultheiss HP, Kolarov P.
et al. Platelet membrane activation markers are predictive for increased risk
of acute ischemic events after PTCA. Circulation.1993;88:37-42.
Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med.1990;322:1549-1554.
Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P. Increased proinflammatory cytokines in patients with chronic stable
angina and their reduction by aspirin. Circulation.1999;100:793-798.
Buffon A, Liuzzo G, Biasucci LM.
et al. Preprocedural serum levels of C-reactive protein predict early complications
and late restenosis after coronary angioplasty. J Am Coll Cardiol.1999;34:1512-1521.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently
healthy men. N Engl J Med.1997;336:973-979. [published correction appears in N Engl J Med. 1997;337:356].
Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? [editorial]. N Engl J Med.2000;342:1907-1909.
Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy
of research designs. N Engl J Med.2000;342:1887-1892.
Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med.2000;342:1878-1886.
Lauer MS. Primary angioplasty: time is of the essence [editorial]. JAMA.2000;283:2988-2989.
Hill AB. The environment and disease: association or causation? Proc R Soc Med.1965;58:295-300.
Bastyr III EJ, Kadrofske MM, Vinik AI. Platelet activity and phosphoinositide turnover increase with advancing
age. Am J Med.1990;88:601-606.